Atlas Trials

Evaluation of the Effects of Multiple Doses of Cebranopadol on the Electrical Activity of the Heart in Healthy Subjects

Clinical trial NCT03958123 · COMPLETED

Trial details

NCT number
NCT03958123
Sponsor
Tris Pharma, Inc.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Prolonged QTc IntervalPharmacokinetic
Start date
2013-07-10
Primary completion
2013-11-27
Enrollment
171

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.